Postpartum Invasive Group A Streptococcal Disease in the Modern Era

Table 1

Clinical, laboratory, and epidemiologic characteristics of postpartum invasive group A streptococcal infections.

Case	Year of admission	Age (years)	Symptom onset (days postpartum)	Race and Hispanic ethnicity	Clinical presentation	Potential risk factors other than peripartum period	GAS^* isolate site(s)	Outcome
1	1996	36	22	White non-Hispanic	Peritonitis	Injecting drug user	Peritoneal fluid	Survived
2	1997	26	1	Black non-Hispanic	Pneumonia	(None)	Genitals, blood	Survived
					Secondary bacteremia
3	1998	29	4	White Hispanic	Endometritis/postpartum sepsis	Surgical wound	Blood	Survived
					Secondary bacteremia	Use of NSAIDs^** in 7 days prior to onset of GAS illness
					STSS^#
4	1999	25	NA	White non-Hispanic	Endometritis/postpartum sepsis	(None)	Blood, vagina	Survived
					Secondary bacteremia

^∗Group A Streptococcus.
^†At the time of admission.
^‡NA: not available.
^#STSS: streptococcal toxic shock syndrome.
^∗∗NSAIDs: nonsteroidal anti-inflammatory drugs.